Daniel Michael Feckoury

Daniel Feckoury practices at Piedmont Physicians at Inman Park in Atlanta, Georgia.

Daniel Feckoury's NPI, 1659516367, was assigned on December 9, 2008. Daniel Feckoury graduated from Mercer University School of Medicine in 2013. Daniel Feckoury holds Georgia license 080953.

Daniel Feckoury's primary practice is Piedmont Physicians at Inman Park, at 2275 Marietta NW Blvd, Atlanta, GA 30318 in Fulton County. The practice phone is (404) 658-9840.

Daniel Feckoury's primary practice is Piedmont Physicians at Inman Park in Atlanta, Georgia. Daniel Feckoury is also affiliated with Tanner Medical Center/Carrollton. The medical group on file is Piedmont Physicians at Inman Park. Dmand AI also links Daniel Feckoury to 1 more hospital, 2 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Feckoury practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Daniel Feckoury's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Daniel Feckoury is licensed in Georgia.

CMS data shows 355 Medicare services from Daniel Feckoury across 4 procedure codes in 2024, for 131 Medicare patients. Medicare paid $21,387 for them. Every service was in an office.

CMS counts 131 Medicare patients who saw Daniel Feckoury in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Daniel Feckoury's median patient age at 51, with 43% women.

In 2024, Daniel Feckoury wrote 2,462 Medicare Part D claims for 272 patients. 88% of them were for generic drugs. CMS names the drug for 1,848 of them, across 57 drugs with 11 or more claims each, at $99,911 in total drug cost. In 2023, CMS named 2,028 claims across 63 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Daniel Feckoury for performance year 2024, reported through an alternative payment model (APM). Daniel Feckoury accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 64 general payments to Daniel Feckoury from 20 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $224.

Daniel Feckoury graduated from Mercer University School of Medicine in 2013.